Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995 - Abstracts

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995
TitleSubjectAuthors
Accuracy of a saliva test for HIV antibody.HealthJulio S.G. Montaner, Michael V. O'Shaughnessy, Arlene King, Stephen A. Marion, Darrel Cook, Michael Rekart, Peter J. Middleton
Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland.HealthDavid Vlahov, David D. Celentano, Alice A. Gleghorn, T. Stephen Jones, Meg C. Doherty
Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS.HealthDonald R. Carrigan, Konstance Kehl Knox
Acute feline leukemia virus infection causes altered energy balance and growth inhibition in weanling cats.HealthKathleen A. Hayes, Lawrence E. Mathes, James R. Hartke, C. Anthony Buffington, Jennifer L. Rojko
AIDS among the homeless of Boston: a cohort study.HealthKenneth A. Freedberg, George R. Seage III, Kathleen M. Gallagher, Joan M. Lebow, James J. O'Connell, Stephanie Oddleifson
AIDS pathogenesis: from models to viral dynamics in patients.(Combination Antiretroviral Therapy for HIV Infection: Proceedings of an International Symposium held in Berlin, Germany, March 25-26, 1995)HealthMartin A. Nowak
AIDS, risk adjustment, and health care financing in New York State.(Henry J. Kaiser Family Foundation Forum on HIV and Managed Care)HealthRobert A. Padgug
Alcohol use, liberal/conservative orientations, and ethnicity as predictors of sexual behaviors.HealthSandra K. Burge, James Alan Neff
A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome.HealthIrving Salit, Sharon Walmsley, Carey Levinton, James Brunton, Derek Muradali, Daniel Rappaport, Miriam Bast, Diana Spence
Analysis of nutritional intake in a cohort of homosexual men.HealthJulio S.G. Montaner, Robert S. Hogg, Kevin J.P. Craib, Martin T. Schechter, Robert Voigt, Joeane N. Zadra, Clifford Chan-Yan, Judit Korosi-Ronco
An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity.(long terminal repeat)HealthGiorgio Zauli, Michele La Placa, Monica Vignoli, Maria Carla Re, Davide Gibellini, Giuliano Furlini, Daniela Milani, Marco Marchisio, Meri Mazzoni, Silvano Capitani
Anti-HIV activity of the combination of didanosine and hydroxyurea in HIV-1-infected individuals.HealthFrancois Biron, Dominique Peyramond, Frederic Lucht, Anne Fresard, Thierry Vallet, Fabienne Nugier, Jacques Grange, Serge Malley, Farid Hamedi-Sangsari, Jorge Vila
A phase I evaluation of concomitant rifabutin and didanosine in symptomatic HIV-infected patients.HealthNanci Hawley-Foss, D. William Cameron, Jan Sahai, Prem K. Narang, Ronald C. Li, Mala Kamal
Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression.HealthF. Pandolfi, M. Pierdominici, A. Oliva, G. D'Offizi, I. Mezzaroma, B. Mollicone, A. Giovannetti, L. Rainaldi, I. Quinti, F. Aiuti
A prospective study of mother-to-infant HIV transmission in tribal women from India.HealthRachana M. Kumar, Sayenna A. Uduman, Ashok K. Khurranna
Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.(immune complex-dissociated, quantitative competitive-polymerase chain reaction)HealthMichael S. Saag, Jeffrey D. Lifson, Emilio A. Emini, George M. Shaw, John C. Kappes, Beatrice H. Hahn, Paul Chopra, Shande Chen, Randi McFarland, Limei C. Yang, Michael Piatak Jr.
A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.HealthDavid H. Schwartz, Judy Lieberman, Miguel-Angel Perales, Jessica A. Fabry
Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome.HealthWilliam G. Powderly, Carl J. Fichtenbaum, W. Claiborne Dunagan
Bacteremia in hospitalized patientsinfected with the human immunodeficiency virus: a case-control study of risk factors and outcome.HealthWilliam G. Powderly, Carl J. Fichtenbaum, W. Claiborne Dunagan
Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection.HealthMichael Ott, Harald Fischer, Hatice Polat, Eike Brigitte Helm, Marcus Frenz, Wolfgang F. Caspary, Bernhard Lembcke
Biological and genetic changes in ovine lentivirus strains following passage in isogeneic twin lambs.HealthTonja M. Woodward, Jonathan O. Carlson, Andres de la Concha-Bermejillo, James C. DeMartini
CD4+ and CD8+ lymphocytes of patients with AIDS synthesize increased amounts of interferon-gamma.HealthArnaldo Caruso, Stefano Licenziati, Adolfo Turano, Angelo Donato Canaris, Antonello Cantalamessa, Susanna Folghera, Maria Antonietta Lonati, Giuseppe De Panfilis, Gianni Garotta
CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis.HealthP. Becker, D.J. Martin, J.G.M. Sim, G.J. Sole, L. Rymer, S. Shalekoff, A.B.N. Van Niekerk, C.N. Weilbach, J. Iwanik, K. Keddy, G.B. Miller, B. Ozbay, A. Ryan, T. Viscovic, M. Woolf
Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men.HealthDavid Vlahov, Alvaro Munoz, Noya Galai, Joseph B. Margolick, Neil M.H. Graham, Chen Kan
Clinical evaluation of Amplicor HIV-1 test for detection of human immunodeficiency virus type 1 proviral DNA in peripheral blood mononuclear cells.HealthA. Khadir, F. Coutlee, P. Saint-Antoine, C. Olivier, H. Voyer, A. Kessous-Elbaz
Clinical experience with atovaquone on a treatment investigational drug protocol for Pneumocystis carinii pneumonia.HealthMichael Rogers, Stephen LaFon, Alice White, Elizabeth Andrews, Nathaniel Brown
Clinical research and drug development of antivirals in HIV: an industry perspective.(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthStephen K. Carter
Clinical spectrum of HTLV-I in South Florida.HealthBernard Poiesz, Glenn Miller, Joseph Berger, Alan Greenberg, Parkash Gill, William J. Harrington Jr., Gerald E. Byrne Jr., Clarence C. Whitcomb, Mark Rabin, Antonio Ucar, Susan Snodgrass, William Sheremata, Lisa Cabral, Walter Voight, Robert Kemper, John J. Byrnes
Combination therapy from a clinician's perspective.(Combination Antiretroviral Therapy for HIV Infection: Proceedings of an International Symposium held in Berlin, Germany, March 25-26, 1995)HealthFrank D. Goebel
Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I study.HealthDouglas D. Richman, Margaret A. Fischl, Sarah H. Cheeseman, Lionel Resnick, Stephen A. Spector, Tze-Chiang Meng, Brian Wright, Ahmad Boota, Tina Petrakis
Comparison of multiple drug therapy regimens for HIV-related disseminated mycobacterium avium complex disease.HealthPatricia Kissinger, Rebecca Clark, Anne Morse, William Brandon
Comparison of partner notification at anonymous and confidential HIV test sites in Colorado.HealthRichard E. Hoffman, Nancy E. Spencer, Lisa A. Miller
Comparison of selective polymerase chain reaction primers and differential probe hybridization of polymerase chain reaction products for determination of relative amounts of codon 215 mutant and wild-type HIV-1 populations.HealthMichelle Stempien, Diana Besemer, Janice Kolberg, P. Scott Eastman, Mickey Urdea
Comparison of the declines in CD4 counts in HIV-1-seropositive female sex workers and women from the general population in Nairobi, Kenya.HealthNico J.D. Nagelkerke, Anthony Mwatha, Stephen Moses, Elizabeth N. Ngugi, Job J. Bwayo, Francis A. Plummer, Aggrey Anzala, Joshua Kimani, Joanne Embree, Shurjeel Choudhri, Jeckoniah O. Ndinya Achola
Complement activation and immune complexes in early congenital HIV infection.HealthJames N. Jarvis, Heide Taylor, Madonna Iobidze
Concordance of PCR and antibody results from HIV testing of injecting drug users.(polymerase chain reaction)HealthAlex H. Kral, John K. Watters, Alan R. Lifson, Mark Stanley, James R. Carlson
Consensus statement.(Scientific Advisory Committee on Surrogate Markers of HIV)(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)Health 
Consumer protections for people living with HIV within systems of managed care.(Henry J. Kaiser Family Foundation Forum on HIV and Managed Care)HealthJeffrey Levi, Helen Schietinger
Continuous low-dose interferon-alpha therapy for HIV-related immune thrombocytopenic purpura.HealthDonald I. Abrams, Edwin D. Charlebois, Lawrence D. Kaplan, Donald W. Northfelt, Carroll Child, Marcela I. Mirda
Cost effectiveness: from whose perspective?(Supplement 4: Cost-Effectiveness and AIDS: Science and Marketing?)HealthAlan L. Hillman
Cryptococcal pneumonia in AIDS: is cryptococcal meningitis preceded by clinically recognizable pneumonia?HealthAlan Sugar, Carol A. Saunders, Jane A. Driver, Beverly Heinse-Lacey
Current HIV clinical trial design issues.(Combination Antiretroviral Therapy for HIV Infection: Proceedings of an International Symposium held in Berlin, Germany, March 25-26, 1995)HealthJoep M.A. Lange
Deferral of blood donors with risk factors for HIV infection saves lives and money in Zimbabwe.HealthD.A. Katzenstein, W. McFarland, J.G. Kahn, D. Mvere, R. Shamu
Derivation and properties of a brief health status assessment instrument for use in HIV disease.HealthRon D. Hays, Albert W. Wu, Samuel A. Bozzette, Sandra H. Berry, David E. Kanouse
Design and assessment of cost-effectiveness studies in AIDS populations.(Supplement 4: Cost-Effectiveness and AIDS: Science and Marketing?)HealthKit N. Simpson
Detection of semen in cervicovaginal secretions.HealthDeborah J. Anderson, Florina Haimovici
Developing quality review criteria from standards of care for HIV disease: a framework.(includes outline of care guidelines to aid formulation of review criteria)(Henry J. Kaiser Family Foundation Forum on HIV and Managed Care)HealthSteven Asch, Samuel A. Bozzette
Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene.HealthShijuan Wu, Xiping Liu, Michelle M. Solorzano, Richard Kwock, Vassilios I. Avramis
Diagnosis and screening of HIV/AIDS using clinical criteria in Tanzanian adults.HealthJohn Shao, Nathan M. Thielman, William C. Miller, Nduminsari Swai, J. Peter Cegielski, Denis Manyenga, Juliana Mlalasi, Gunther J. Lallinger
Diagnosis of HIV-1 infection with whole saliva by detection of antibody IgG to HIV-1 with ultrasensitive enzyme immunoassay using recombinant reverse transcriptase as antigen.HealthAtsushi Saitoh, Hideo Shinagawa, Shinichi Oka, Setsuko Ishikawa, Seiichi Hashida, Hashinaka Kazuya, Kouichi Hirota, Akihisa Takamizawa, Kaoru Shimada, Eiji Ishikawa
Diagnostic utility of immune-complex-dissociated p24 antigen detection in perinatally acquired HIV-1 infection in Rwanda.HealthMarc Bulterys, Homayoon Farzadegan, Alfred J. Saah, Ann Chao, Abel Dushimimana, Anne Voltz, Paula Nawrocki, Jean-Baptiste Kurawige
Diminished expression of cell-surface complement regulatory proteins in HIV-infected children and with HIV infection of peripheral blood mononuclear cells in vitro.HealthJames N. Jarvis, Heide Taylor, P. Michael Long, P. Vani Gutta, Tracey Pousak, Nancy Fine
Disseminated Mycobacterium avium infection among HIV-infected patients in Kenya.HealthC. Fordham von Reyn, Charles F. Gilks, Richard J. Brindle, Christine Mwachari, Barry Batchelor, Joab Bwayo, Joseph Kimari, Robert D. Arbeit
Dynamics of risk behavior for HIV infection among young Thai men.HealthDavid D. Celentano, Noya Galai, Kenrad E. Nelson, Somboon Suprasert, Nicholas Wright, Sakol Eiumtrakul, Surinda Kuntolbutra, Choti Theetranont
Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.(ddI)HealthL. Kaiser, S. Yerly, C. Baumberger, B. Hirschel, L.H. Perrin
Early suppression of viremia by ZDV does not alter the spread of feline immunodeficiency virus infection in cats.(zidovudine)HealthKathleen A. Hayes, Lawrence E. Mathes, Julie G. Wilkinson, Richard Frick, Sabine Francke
Editorial.(on review article of gynecological diseases in HIV infected women in this issue)(Editorial)HealthRichard L. Sweet
Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo.HealthM.C. Re, G. Furlini, M. Vignoli, E. Ramazzotti, G. Roderigo, V. De Rosa, G. Zauli, S. Lolli, S. Capitani, M. La Placa
Effect of a retroviral immunodeficiency syndrome on resistance to MCMV: a role for natural killer cells.(murine cytomegalovirus)HealthPatricia Price, Craig D. Peacock
Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity.HealthJ. Neyts, E. De Clerca
Effects of interleukin-1 and interleukin-1 receptor antagonist in AIDS-Kaposi's sarcoma.HealthParkash Gill, George Lin, Stan Louie, Jie Cai, Ron Law, Yanto Lunardi-Iskandar, Bruce Jung, Rizwan Masood
Effects of viral virulence on intrauterine growth in SIV-infected fetal Rhesus macaques (Macaca mulatta).HealthChristopher J. Miller, Marta L. Marthas, Alice F. Tarantal, Sharron E. Gargosky, Moses Otysula, Michael B. McChesney, Andrew G. Hendrickx
Efficacy, safety, and tolerance of low-dose, long-term interferon-alpha(2b) and zidovudine in early-stage AIDS-associated Kaposi's sarcoma.HealthStefan Mauss, Helmut Jablonowski
Envelope V3 region sequences of Cuban HIV-1 isolates.HealthMark A. Wainberg, Felipe M. Rolo, Lazaro Miranda, Zhengxian Gu, Leonor Lobaina, Enrique Noa, Jorge Mato, Francisco Machado, Zonia Martin
Evaluating surrogate markers. (of HIV infection)(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthMichael D. Hughes, Victor DeGruttola, Seth L. Welles
Evaluating the cost-effectiveness of pharmacologic therapy: where we've been and where we're going.(Supplement 4: Cost-Effectiveness and AIDS: Science and Marketing?)HealthArnold M. Epstein
Evidence for a shift from a type I lymphocyte pattern with HIV disease progression.HealthJ. Murphy, J. Jason, L.A. Sleeper, S.M. Donfield, I. Warrier, S. Arkin, B. Evatt
Evidence of active cytomegalovirus infection in clinically stable HIV-infected individuals with CD4+ lymphocyte counts below 100/microliters of blood: features and relation to risk of subsequent CMV retinitis.(cytomegalovirus)HealthRichard L. Hodinka, Harvey M. Friedman, Rob Roy MacGregor, Amy L. Graziani, Stephen J. Pakola, Dan P. Montzka, Charles W. Nichols
Expression of nuclear lectin carbohydrate-binding protein 35 in human immunodeficiency virus type 1-infected Molt-3 cells.HealthWerner E.G. Muller, Heinz C. Schroder, Hiroshi Ushijima, Corinna Theis, Annie-Pierre Seve, Jean Hubert
Failure of high-dose oral acyclovir to suppress CMV viruria or induce ganciclovir-resistant CMV in HIV antibody positive patients.HealthW.L. Drew, R. Anderson, W. Lang, R.C. Miner, G. Davis, J. Lalezari
Four years of natural history of HIV-1 infection in African women: a prospective cohort study in Kigali (Rwanda), 1988-1993.HealthFrancois Dabis, Roger Salamon, Valeriane Leroy, Philippe Van de Perre, Henri Taelman, Philippe Lepage, Arlette Simonon, Jean Batungwanayo, Phillippe Msellati, Deo-Gratias Hitimana, Jos Begaerts, Francoise Boineau
Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein.HealthWilliam A. Haseltine, Eric A. Cohen, Jacques Friborg, Azim Ladha, Heinrich Gottlinger
Functional analysis of the vpx, vpr, and nef genes of the simian immunodeficiency virus.HealthJoseph Sodroski, In-Woo Park
Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosine.HealthBernard Masquelier, Philippe Morlat, Jean-Marie Ragnaud, Herve J.A. Fleury, Christian Michelet, Isabelle Pellegrin, Annick Ruffault, Francois Doignon, Nicolas Biteau
Gynecologic disease in women infected with human immunodeficiency virus type 1.(review article)HealthDaniel V. Landers, Abner P. Korn
Health insurance and use of medical services by men infected with HIV.HealthMitchell H. Katz, Susan P. Buchbinder, Nancy A. Hessol, Lynda S. Doll, Sophia W. Chang, Paul O'Malley
Health insurance and use of medicalservices by men infected with HIV.HealthMitchell H. Katz, Susan P. Buchbinder, Nancy A. Hessol, Lynda S. Doll, Sophia W. Chang, Paul O'Malley
Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture.HealthRobert C. Gallo, Ephata E. Kaaya, Carlo Parravicini, Cosme Ordonez, Rita Gendelman, E. Berti, Peter Biberfeld
HIV-1, HIV-2, HTLV-I/II and Treponema pallidum infections: incidence, prevalence, and HIV-2-associated mortality in an occupational cohort in Guinea-Bissau.HealthSoren Andersson, Anders Naucler, Gunnel Biberfeld, Hans Norrgren, Fransisco Dias, Ingrid Johansson
HIV-1 infection of human brain-derived microvascular endothelial cells in vitro.HealthG.P.A. Rice, S.D. Poland, G.A. Dekaban
HIV and managed care: implications for academic medicine.(Henry J. Kaiser Family Foundation Forum on HIV and Managed Care)HealthHarvey J. Makadon, William J. Aseltyne
HIV care: a capitated alternative.(Henry J. Kaiser Family Foundation Forum on HIV and Managed Care)HealthDavid L. Knowlton
HIV care: a changing health care system.(Henry J. Kaiser Family Foundation Forum on HIV and Managed Care)HealthJames O. Kahn, Mark D. Smith
HIV dementia scale: a rapid screening test.HealthOla A. Selnes, Justin C. McArthur, Christopher Power, Julie A. Grim
HIV disease and managed care: an overview.(Henry J. Kaiser Family Foundation Forum on HIV and Managed Care)HealthMark D. Smith, William J. Aseltyne, Mark Cloutier
HIV/HTLV-1 coinfection and clinical grade at diagnosis.(human T-cell lymphotropic virus)HealthM. Chavance, C. Neisson-Vernant, D. Quist, N. Monplaisir, B. Armengaud, R. Chout
HIV/HTLV-1 coinfection and clinicalgrade at diagnosis.(human T-cell lymphotropic virus)HealthM. Chavance, C. Neisson-Vernant, D. Quist, N. Monplaisir, B. Armengaud, R. Chout
HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data.HealthEdward H. Kaplan, Robert Heimer
HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update.HealthRobert J. Battjes, Roy W. Pickens, Lawrence S. Jr. Brown
HIV infection in women: an observational study of clinical characteristics, disease progression, and survival for a cohort of women in Chicago.HealthHarold A. Kessler, Constance A. Benson, Beverly E. Sha, Pamela A. Urbanski, John C. Pottage Jr., Steven R. Daugherty
HIV in injecting drug users in Edinburgh: prevalence and correlates.HealthAntony G. Davies, Nicola J. Dominy, Andrew Peters, George E. Bath, Sheila M. Burns, Alison M. Richardson
HIV pathogenesis and treatment strategies.(Combination Antiretroviral Therapy for HIV Infection: Proceedings of an International Symposium held in Berlin, Germany, March 25-26, 1995)HealthStefano Vella
HIV prevalence and sexual behavior in a cohort of New York City gay men (aged 18-24).(Rapid Communication)HealthIlan Meyer, Laura Dean
HIV risk adjustment: issues and proposed approaches.(Henry J. Kaiser Family Foundation Forum on HIV and Managed Care)HealthJames G. Kahn, Mark D. Smith, Harold Luft
Hospital admissions of HIV-infected patients from 1988 to 1992 in Maryland.HealthRichard D. Moore, Ilana S. Fortgang
How important is race/ethnicity as an indicator of risk for specific AIDS-defining conditions?HealthTimothy J. Bush, Dale J. Hu, Jeffrey L. Jones, Patricia L. Fleming, John W. Ward, Susan Y. Chu, Kenneth G. Castro, Jonathan Kaplan, Debra Hanson
HTLV-I infection among prostitutes and pregnant women in Kinshasa, Zaire: how important is high-risk sexual behavior?HealthEric Delaporte, Anne Buve, Peter Piot, Nzilambi Nzila, Marie Laga, William Heyward, Johan Goeman, Marie-Christine Dazza, Daniel Henzel, Michael St-Louis
Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.HealthDaniela Fenoglio, Giuseppina Li Pira, Luisa Lozzi, Daniele Saverino, Fabrizio Manca, George Lewis, Maria T. Valle, Annalisa Kunkl, Anna Ferraris, Flavia Lancia, Lorenzo Mortara, Michel Pierres, Angus G. Dalgleish
Human herpesvirus-6 and the course of human immunodeficiency virus infection.HealthM. Valle Blazquez, Juan A. Madueno, Rafael Jurado, Nieves Fernandez-Arcas, Eduardo Munoz
Human immunodeficiency virus type-1 seroconversion trends among young adults serving in the United States Army, 1985-1993.HealthJohn G. McNeil, John F. Brundage, Z. Frank Wann, Donald S. Burke, Philip O. Renzullo
Humoral responses to linear epitopes on the HIV-1 envelope in seropositive volunteers after vaccine therapy with rgp160.HealthDeborah L. Birx, Donald S. Burke, Robert R. Redfield, Lawrence D. Loomis, Carolyn D. Deal, Kathryn S. Kersey
Identification of a clonal form of HIV in early Kaposi's sarcoma: evidence for a novel model of oncogenesis, "sequential neoplasia."HealthBrian G. Herndier, Bruce T. Shiramizu, Michael S. McGrath
Identification of IIa and IIb molecular subtypes of human T-cell lymphotropic virus type II among Italian injecting drug users.HealthUmberto Bertazzoni, Claudio Casoli, Marco Salemi, Ercole Cattaneo
IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage.(interleukin)HealthAnthony S. Fauci, Guido Poli, Drew Weissman
IL-6 induces target cell resistance to HIV-specific cytotoxic lysis.HealthMin Liu, Otoniel Martinez-Maza, Tadamitsu Kishimoto, Michael T. Johnson, Jiang Fan, Susan Plaeger
Illness stage, concurrent medications, and other correlates of low testosterone in men with HIV illness.HealthJudith G. Rabkin, Glenn Wagner, Richard Rabkin
Immunodominant epitope regions of HIV-1 reverse transcriptase: correlations with HIV-1+ serum IgG inhibitory to polymerase activity and with disease progression.HealthJeffrey Laurence, Bryn Grimison
Immunologic and virologic markers determining progression to AIDS.(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthFrank Miedema, Matthijs Tersmette, Maarten Koot, Peter T.A. Schellekens, Marijke T.L. Roos
Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales - Connecticut, 1992-1993.HealthLinda A. Valleroy, Robert T. Rolfs, Samuel L. Groseclose, Beth Weinstein, T. Stephen Jones, William J. Kassler
Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers - Connecticut, 1992-1993.HealthLinda A. Valleroy, Samuel L. Groseclose, Beth Weinstein, T. Stephen Jones, William J. Kassler, Laura J. Fehrs
Incentives and disincentives to participate in prophylactic HIV vaccine research.HealthRichard A. Jenkins, Lydia R. Temoshok, Kittichatr Virochsiri
Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients.HealthJohann Ockenga, Ulrich Suttmann, Oliver Selberg, Linda Hoogestraat, Helmuth Deicher, Manfred James Muller
Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A.HealthDavid Vlahov, Noya Galai, Ellen Taylor, Rima F. Khabbaz, Jonathan E. Kaplan, Sylvia Cohn
Incidence proportion of and risk factors for AIDS patients diagnosed with HIV dementia, central nervous system toxoplasmosis, and cryptococcal meningitis.HealthEric Vittinghoff, Arthur Reingold, Edwin Lewis, Fong Wang, Yuen So, Hina Malani, James Girodano, Robert Janssen
Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.HealthEric A. Cohen, Heinrich G. Gottlinger, Dominique Bergeron, Florent Checroune, Xiao-Jian Yao
Increased mRNA expression of IL-6, IL-10, TNF-alpha, and perforin in blood mononuclear cells in human infection.(interleukin, tumor necrosis factor)HealthB. Wahren, J. Link, V. Navikas, C. Persson, T. Olsson, B. Hojeberg, A. Ljungdahl, H. Link
Increase in percentage of CD45RO+/CD8+ cells is associated with previous severe primary HIV infection.HealthBente Klarlund Pedersen, Court Pedersen, Helle Bruunsgaard, Elma Scheibel
Incubation period of vertically acquired AIDS in Europe before widespread use of prophylactic therapies.HealthAngela M. Downs, Rosemary A. Ancelle-Park, Giuseppe Salamina
Individualization of therapy using viral markers.(Combination Antiretroviral Therapy for HIV Infection: Proceedings of an International Symposium held in Berlin, Germany, March 25-26, 1995)HealthThomas Merigan
Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.HealthMagali Cucchiarini, Laurence Cagnon, Valerie Giordanengo, Alain Doglio, Jean-Claude Lefebvre
Infection of baboons with simian human immunodeficiency viruses.HealthJoseph Sodroski, Cecilia Cheng-Mayer, John Li, Jay A. Levy, Jonathan S. Allan, Thomas Butler, Pamela Ray, Suzanne Broussard, Evelyn Eaton Whitehead, Gene Hubbard, Kathleen Brasky, Paul Luciw, Kathelyn Steimer, Maria Garcia-Moll
Influence of HIV epidemic on the incidence of Kaposi's sarcoma in Zambian children.HealthUma H. Athale, P.S. Patil, C. Chintu, B. Elem
Inhibition of cytotoxicity and cytokine release of CD8+ HIV-specific cytotoxic T lymphocytes by pentoxifylline.HealthBruce D. Walker, Christian Jassoy, Martin Heinkelein, Jurgen Schneider-Schaulies
Insights from monitoring the CPCRA didanosine/zalcitabine trial.(Community Programs for Clinical Research on AIDS)(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthJames D. Neaton, David L. DeMets, Thomas R. Fleming, Anne Goldman, Donald Abrams, Cynthia Launer, Joyce Korvick
Inter-company collaboration combination trials. (Inter-Company Collaboration for AIDS Drug Development)(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthDavid W. Barry, Whaijen Soo, Cheryl Nauss-Karol, James Rooney, Mary Elkins
In vitro comparison of selected triple-drug combinations for suppression of HIV-1 replication: the inter-company collaboration protocol.(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthDavid W. Barry, Marty H. St. Clair, James Rooney, Kevin N. Pennington
L-2-oxothiazolidine-4-carboxylic acid (Procysteine) inhibits expression of the human immunodeficiency virus and expression of the interleukin-2 receptor alpha chain.HealthMichael M. Lederman, Daniel Georges, Stephen Dando, Rodney Schmelzer, Lynne Averill, Dennis Goldberg
Life span of circulating membrane CD4 inserted into the plasma membranes of autologous red blood cells of HIV-infected subjects.HealthF. Blaine Hollinger, Pierre-Francois Tosi, Claude Nicolau, Youssef Mouneimne, Chris Lahart, Dimitre Dimitrov
Listeria monocytogenes infection and serotype distribution among HIV-infected persons in Los Angeles County, 1985-1992.HealthLaurene Mascola, Peggy S. Hayes, Michael W. Reeves, Donnell P. Ewert, Loren Lieb
Localized or systemic in vivo heat inactivation of human immunodeficiency virus (HIV): a mathematical analysis.HealthDaniel I. Sessler, Alan S. Perelson, George Nelson, Carlton Pennypacker, Nathalie Nys
Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+ lymphocytes.HealthAlvaro Munoz, Joseph B. Margolick, Charles R. Rinaldo, John P. Phair, Barbara R. Visscher, Richard A. Kaslow, Alison J. Kirby, Yanhua D. He
Male circumcision, sexually transmitted disease, and risk of HIV.HealthMichel Carael, Susan Allen, Antoine Serufilira, Francois Nsengumuremyi, Etienne Karita, Jeff Seed, Thierry Mertens, Esther Hudes, Philippe Van de Perre
Managed care, AIDS, and the politics of risk.(Henry J. Kaiser Family Foundation Forum on HIV and Managed Care)HealthTim Westmoreland
Markers and determinants of disease progression in children with HIV infection.(Report of a Consensus Workshop, Siena, Italy, June 4-6, 1993)HealthPhilip A. Pizzo, Catherine M. Wilfert
Markers and determinants of diseaseprogression in children with HIV infection.(Report of a Consensus Workshop, Siena, Italy, June 4-6, 1993)HealthPhilip A. Pizzo, Catherine M. Wilfert
Maternal factors associated with perinatal HIV-1 transmission: the French Cohort Study: 7 years of follow-up observation.HealthGhislaine Firtion, Christine Rouzioux, Marie-Jeanne Mayaux, Stephane Blanche, Joelle Tricoire, Christian Courpotin, Francois Guillot, Marie-Christine Allemon, Etienne Vilmer, Jerome Le Chenadec, Veronique Chambrin, Nicole Ciraru Vigneron
Measuring viral load in the clinical setting.(Combination Antiretroviral Therapy for HIV Infection: Proceedings of an International Symposium held in Berlin, Germany, March 25-26, 1995)HealthRichard Harrigan
Mechanism of HIV persistence: implications for vaccines and therapy.HealthHans J. Bremermann
Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial.HealthMary Lou Clements, Katherine Harrison, David Ulahov, Kathleen Jones, Karen Charron
Multiple superinfections fail to activate defective human immunodeficiency virus-1 (HIV-1) infection of rabbits.HealthStewart Sell, C.K. Tseng
Multisite evaluation of four anti-HIV-1/HIV-2 enzyme immunoassays.HealthElizabeth M. Dax, Colin Silvester, David S. Healey, Philip Cunningham
Mycobacterium avium complex in water, food, and soil samples collected from the environment of HIV-infected individuals.HealthArthur L. Reingold, C. Robert Horsburgh Jr., Daniel P. Chin, Stephen M. Ostroff, Philip C. Hopewell, W. Keith Hadley, Mitchell A. Yakrus, David M. Yajiko, Patricia C. Gonzales, Patricia S. Nassos
Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+ CD56+ cells and expansion of a population of CD16(dim)CD56- cells with low lytic activity.HealthRoger Detels, Janis V. Giorgi, Karim Hirji, Lance E. Hultin, Mary Ann Hausner, Pei-Feng Hu, Patricia Hultin, Anahid Jewett, Benjamin Bonavida
Neither whole inactivated virus immunogen nor passive immunoglobulin transfer protects against SIVagm infection in the African green monkey natural host.HealthFelix Siegel, Reinhard Kurth, Stephen Norley
Neurologic manifestations of AIDS: a comparative study of two populations from Mexico and the United States.HealthMax Essex, Victor M. Rivera, J. Roberto Trujillo, Guillermo Garcia-Ramos, Irwin S. Novak, Enrique Huerta
Neutralizing antibodies in slowly progressing HIV-1 infection.HealthKristian Schonning, Claus Nielsen, Jens Ole Nielsen, Johan Iversen, John-Erik Stig Hansen
Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.HealthDavid M. Simpson, Michele Tagliati
Pathogenic insights from studies of lymphoid tissue from HIV-infected individuals.(Combination Antiretroviral Therapy for HIV Infection: Proceedings of an International Symposium held in Berlin, Germany, March 25-26, 1995)HealthGiuseppe Pantaleo, Anthony S. Fauci, Oren J. Cohen, Douglas J. Schwartzentruber, Cecilia Graziosi, Mauro Vaccarezza
Pathologic and serologic responses of isogeneic twin lambs to phenotypically distinct lentiviruses.HealthA. de la Concha-Bermejillo, S.J. Brodie, S. Magnus-Corral, R.A. Bowen, J.C. DeMartini
PCR analysis of HIV-seronegative, heterosexual partners of HIV-infected individuals. (polymerase chain reaction)HealthPaul Palumbo, Dan Lewis, Joan Skurnick, Marcia Eisenberg
Performance characteristics for the quantification of plasma HIV-1 RNA using branched DNA signal amplification technology.(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthDavid Chernoff, David Kern, Mark Holodniy, Carol Pachl, Torange Yeghiazarian, Mickey Urdea, John Todd, Roseann White, Pamela Johnson, Beverly Taylor, Sarah Hamren
Pharmacokinetics of simultaneously administered zidovudine and didanosine in HIV-seropositive male patients.HealthKeith Gallicano, Jan Sahai, Gary Garber, Attila Pakuts, William Cameron
Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus.HealthDouglas D. Richman, John Lawrence Sullivan, Sarah H. Cheeseman, David Hall, Stephen A. Spector, Maureen Myers, Daniel S. Stein, Thomas C. Greenough, Diane Havlir, Margaret M. McLaughlin, Susan E. Hattox
Phase I study of high-dose, intravenous rsCD4 in subjects with advanced HIV-1 infection.HealthAnn C. Collier, Lawrence Corey, Timothy Schacker, Jashvant D. Unadkat, Robert Coombs, Irving Fox, John Alam, Ji-Ping Wang, Eric Eggert
Photodynamic therapy in AIDS-related cutaneous Kaposi's sarcoma.HealthPeter Reiss, Piet J.M. Bakker, Konnie M. Hebeda, Manon T. Huizing, Patrick A. Brouwer, Freerk W. van der Meulen, Hendrik J. Hulsebosch, J. (Hans) Oosting, Cees H.N. Veenhof
Positive correlation between the natural killer and gp120/41-specific antibody-dependent cellular cytotoxic effector functions in HIV-infected individuals.HealthAli Ahmad, Jose Menezes
Potential and actual workdays lost among patients with HIV.HealthJames F. Fries, J. Paul Leigh, Deborah P. Lubeck, Paul Farnham
Potential applications of proviral load measurement in clinical retrovirology.(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthBrian Conway, Julio S.G. Montaner, Janet Raboud, Michael Monpetit, Teresa Salas, Daniel Dufour, Michale V.O. O'Shaughnessy
Predictive markers for mother-to-child transmission of HIV-1 in Dar es Salaam, Tanzania.HealthW. Urassa, E. Mbena, F. Mhalu, G. Biberfeld, U. Bredberg-Raden, E. Urassa, E. Lyamuya, G. Msemo, G. Kawo, T. Kazimoto, A. Massawe, O. Grankvist, K. Karlsson
Predictors of HIV disease progression in women.HealthRebecca A. Clark, Sally A. Blakley, Janet Rice, William Brandon
Prenatal care of HIV-infected women: analysis of a large New York state cohort.HealthJames Cocroft, Barbara J. Turner, Thomas Fanning, Leona Markson, Walter Hauck
Prevalence, incidence, and risks for HIV-1 infection in female sex workers in Miami, Florida.HealthIda M. Onorato, David Withum, Winslow Klaskala, W. Meade Morgan
Protection of a T-cell line from human immunodeficiency virus replication by the stable expression of a short antisense RNA sequence carried by a shuttle RNA molecule.HealthMagali Cucchiarini, Laurence Cagnon, Alain Doglio, Jean-Claude Lefebvre
Quality of care and HIV infection: theory and practice.(Henry J. Kaiser Family Foundation Forum on HIV and Managed Care)HealthIra B. Wilson
Quantification of HTLV-II proviral copies by competitive polymerase chain reaction in peripheral blood mononuclear cells of Italian injecting drug users, Central Africans, and Amerindians.(human T-cell leukemia virus type II)HealthA. Gessain, A. Cimarelli, C. Angelin Duclos, E. Cattaneo, C. Casoli, M. Biglione, P. Mauclere, U. Bertazzoni
Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV-infected individuals.(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthJulio S.G. Montaner, Martin T. Schechter, Janet M. Raboud, Lawrence Haley, Carol Murphy, Mariola Januszewska
Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities.HealthPeter Schmid, Wallace W. Tourtellotte, Andrew J. Conrad, Karl Syndulko, Elyse J. Singer, Rashed M. Nagra, James J. Russell
Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay.HealthJohn A. Todd, Carol Pachl, David G. Kern, Patrick J. Sheridan, Sue-Jane Fong, Michelle Stempien, Bradley Hoo, Diana Besemer, Torange Yeghiazarian, Bruce Irvine, Janice Kolberg, Robert Kokka, Paul Neuwald, Mickey S. Urdea
Rapid screening of antiretroviral combinations.(Combination Antiretroviral Therapy for HIV Infection: Proceedings of an International Symposium held in Berlin, Germany, March 25-26, 1995)HealthDavid W. Barry, James Rooney, Kevin N. Pennington, Marty St. Clair
Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies.(The Working Group on Mother-to-Child Transmission of HIV)Health 
Rationale and experience with reverse transcriptase inhibitors and protease inhibitors.(Combination Antiretroviral Therapy for HIV Infection: Proceedings of an International Symposium held in Berlin, Germany, March 25-26, 1995)HealthStefano Vella
Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes.HealthScott D. Holmberg, David Vlahov, Sylvia Cohn, Lois J. Conley, Stephen P. Luby, Leeyang C. Wong
Recent trends in Pneumocystis carinii pneumonia as AIDS-defining disease in nine European countries.HealthAngela M. Downs, Rosemary A. Ancelle-Park, Jean-Baptiste Brunet, Marie-Christine Delmas, Valerie Schwoebel, Simon H. Heisterkamp
Reconsidering the use of adjunctive corticosteroids in Pneumocystis pneumonia?(Editorial)HealthSally C. Morton, Samuel A. Bozzette
Relation between human T-lymphotropic virus type I and neurologic diseases in Panama: 1985-1990.HealthWilliam Blattner, Walid Heneine, Jonathan E. Kaplan, Beverly Roberts, Fernando Gracia, Luis C. Castillo, Mario Larreategui, Victor Cedeno, Paul H. Levine
Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection.HealthWilliam G. Powderly, David B. Clifford, Carl J. Fichtenbaum
Risk factors for HTLV-I among heterosexual STD clinic attenders. (sexually transmitted disease)HealthJ. Morris, J.P. Figueroa, A. Brathwaite, E. Ward, A. Peruga, R. Hayes, S.H. Vermund, W. Blattner
Risk factors for maternal HTLV-I infection in French Guiana: high HTLV-I prevalence in the Noir Marron population.HealthAntoine Gessain, Guy de The, Gabriel Carles, Philippe Tuppin, Jean-Francois Lepere, Abel Ureta-Vidal, Yann Gerard, Christian Peneau, Patricia Tortevoye, Jean-Paul Moreau
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial.HealthGildon Beall, Marcus A. Conant, Jeffrey E. Galpin, Leonard H. Calabrese, Gideon Goldstein, Howard A. Grossman, Gary Blick, Robert L. Hirsch, Alan Fisher, Patti Stampone, Linda A. Meyerson
Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen: results of a double-blind, adjuvant controlled trial.(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthRonald B. Moss, Dennis J. Carlo, Fred Jensen, Richard J. Trauger, Anne E. Diagle, Wieslawa Giermankowska
Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complex.HealthAnn C. Collier, Lawrence Corey, David Katzenstein, Allen E. Izu, Mark Holodniy, Robert W. Coombs, Joyce Mordenti, Thomas Merigan, Joel Gibson, Anne Marie Duliege, Arthur J. Ammann
Sampling lymph node content of human immunodeficiency virus type 1 nucleic acids and p24 antigen by fine-needle aspiration in early-stage patients.(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthArthur E. Brown, Douglas L. Mayers, John D. Malone, David W. Anderson, John DeNobile, Fu Zhao, Maryanne Vahey, James Lane, Martin Nau, Scott A. Wegner, Kenneth Wagner, Bimal Ghosh, J.D. Cotelingam
Score cards for AIDS care.HealthCharles L. Bennett, Robert A. Weinstein, Barrie R. Cassileth, Jack A. DeHovitz
Sequence specificity in the higher-order interaction of the Rev protein of HIV-1 with its target sequence, the RRE.HealthPaul T. Wingfield, Douglas M. Powell, Ming Jie Zhang, Danielle A.M. Konings, Stephen J. Stahl, Elahe T. Dayton, Andrew I. Dayton
Serial HIV seroprevalence surveys: interpretation, design, and role in HIV/AIDS prediction.HealthA.E. Ades
Serum beta2-microglobulin and prediction of progression to AIDS in HIV-infected injection drug users.HealthJesus Diez, Jose M. Zabay, Jose M. Sempere, Jose M. Benito, Beatriz Gonzalez, Eva Obregon, Eduardo Fernandez-Cruz
Sodium butyrate stimulation of HIV-1 gene expression: a novel mechanism of induction dependent of NF-kappaB. (nuclear factor)HealthRoger J. Pomerantz, Mark A. Laughlin, Gloria Y. Chang, Joseph W. Oakes, Francisco Gonzalez-Scarano
Strategies for addressing the social and behavioral challenges of prophylactic HIV vaccine trials.HealthThomas J. Coates, Peter Lurie, Margaret A. Chesney
Strategies for limiting the spread of HIV in developing countries: conclusions based on studies of the dynamics of the virus.HealthRoy M. Anderson, Geoff P. Garnett
Strategies for prevention of perinatal transmission of HIV infection: Siena Consensus Workshop II. (Siena, Italy, June 3-6, 1993)Health 
Studies of zidovudine in combination with didanosine and zalcitabine.(Combination Antiretroviral Therapy for HIV Infection: Proceedings of an International Symposium held in Berlin, Germany, March 25-26, 1995)HealthHelmut Jablonowski
Substitution of didanosine sachets by chewable tablets: a pharmacokinetic study in patients with AIDS.HealthDavid Burger, Jan Mulder, Pieter Meenhorst, Jeanette Henrichs, Jos Frissen, Frank Kroon, Chris ten Napel, Kees Koks, Auke Bult, Jos Beijnen
Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes.HealthMasanori Baba, Koh-ichi Hashimoto, Shiro Shigeta
Survival effects of ZDV, ddI, and ddC on patients with CD4 <= 50 cells/mm3.(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthKazem Kazempour, Lisa A. Kammerman, Shahla Farr S.
The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection.HealthAxel Ullrich, Marcello Piazza, Antonio Chirianni, Stefano Iacobelli, Luigi Ortona, Clara Natoli, Enrica Tamburrini, Laura Sighinolfi, Nicola Tinari, Maurizia D'Egidio, Florio Ghinelli, Luca Guerra
The consequences of a positive prenatal HIV antibody test for women.HealthMolly Cooke, Margaret A. Chesney, Patricia Lester, John Colin Partridge
The duration of breastfeeding by HIV-1-infected mothers in developing countries: balancing benefits and risks.HealthNico J.D. Nagelkerke, Stephen Moses, Francis A. Plummer, Joanne E. Embree, Francoise Jenniskens
The epidemic of HIV AIDS in Abidjan, Cote d'Ivoire: a review of data collected by Projet RETRO-CI from 1987 to 1993.HealthKevin M. De Cock, Madeleine Sassan-Morokro, Alan E. Greenberg, Ehounou Ekpini, Gaston Djomand, Emmanuel Gnaore, Koudou Odehouri, Benoit Soro, Odette Tossou, Mamadou O. Diallo, Peter Ghys, Kari Brattegaard, Achy Yapi, Doulhourou Coulibaly, Issa-Malick Coulibaly, Auguste Kadio
The impact of physician financial incentives on high-risk populations in managed care.(Henry J. Kaiser Family Foundation Forum on HIV and Managed Care)HealthAlan L. Hillman
The learning curve for AIDS-related Pneumocystis carinii pneumonia: experience from 3,981 cases in Veterans Affairs hospitals 1987-1991.HealthJohn Adams, Charles L. Bennett, Russell L. Bennett, Daniel Rodrique, Lance George, Barrie Cassileth, Stuart C. Gilman
The morphogenesis of a Chinese strain of HIV-1 forming inclusion bodies in Jurkat-tat III cells.HealthGoran Wadell, Quan-gen Li, Yi-jun Zhang, Yong Liang, Chuan-quian Feng, Yuan-zhi Li, Rolf Sjoberg, Yi Jiang, Ning-fang Wang
The prognostic value of plasma viremia in HIV-infected patients under AZT treatment: a two-year follow-up study.HealthA. Ruffault, C. Michelet, C. Jacquelinet, O. Guist'hau, N. Genetet, C. Bariou, R. Colimon, F. Cartier
Therapeutic interventions in primary HIV infection.(Combination Antiretroviral Therapy for HIV Infection: Proceedings of an International Symposium held in Berlin, Germany, March 25-26, 1995)HealthL. Perrin, S. Kinloch-de Loes
The rocky road to an AIDS vaccine.(Editorial)HealthJune E. Osborn
The role of atovaquone tablets in treating Pneumocystis carinii pneumonia. (review article)HealthWalter T. Hughes
The role of viral diversity in HIV pathogenesis.(Combination Antiretroviral Therapy for HIV Infection: Proceedings of an International Symposium held in Berlin, Germany, March 25-26, 1995)HealthJaap Goudsmit
Thymic immunopathology and progression of SIVsm infection in cynomolgus monkeys.HealthG. Biberfeld, Su-Ling Li, E.E. Kaaya, C. Ordonez, M. Ekman, H. Feichtinger, P. Putkonen, Disa Bottiger, P. Biberfeld
Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells.HealthMichael J. Rieder, Richard Krause, Gregory A. Dekaban, Ingrid A. Bird
Transient high titers of HIV-1 in plasma and progression of disease.HealthSusan A. Fiscus, Aline Heggem-Snow, Luigi Troiani, Ewa Wallmark, James D. Folds, Brian Sheff, Charles M. Van der Horst
Treatment with letrazuril of refractory cryptosporidial diarrhea complicating AIDS.HealthM. Loeb, A. Rachlis, I. Salit, S. Walmsley, J. Phillips, C. Walach, I. Fong
Trends in HIV seroprevalence among persons attending sexually transmitted disease clinics in the United States, 1988-1992.HealthMarta Gwinn, Lyle R. Petersen, Hillard S. Weinstock, Jasjeet Sidhu, John Karon
Trends in incidence and prevalence of HIV-1 infection in intravenous drug users in Valencia, Spain.HealthMarisa Rebagliato, Isabel Ruiz, Santiago Perez-Hoyos, Maria Jose Avino, Ildefonso Hernandez-Aguado, Francisco Bolumar, Lidia Ferrer
Triple combinations: present and future.(Combination Antiretroviral Therapy for HIV Infection: Proceedings of an International Symposium held in Berlin, Germany, March 25-26, 1995)HealthJoep M.A. Lange
Understanding the essentials of economic evaluation.(Supplement 4: Cost-Effectiveness and AIDS: Science and Marketing?)HealthGeorge P. Schmid
Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy.HealthDiane E. Griffin, Justin C. McArthur, John W. Griffin, Steven L. Wesselingh, William R. Tyor
Uptake and binding of liposomal 2',3'-dideoxycytidine by RAW 264.7 cells: a three-step process.HealthMichel G. Bergeron, Michel Tremblay, Denis Beauchamp, Boby Makabi-Panzu, Celine Lessard, Andre Desormeaux, Louise Poulin
Use of the Markov model to estimate the waiting times in a modified WHO staging system for HIV infection.HealthJulio S.G. Montaner, Michael V. O'Shaughnessy, Kevin J.P. Craib, Martin T. Schechter, Thinh N. Le, Nhu Le
U.S. hospital care for HIV-infected persons and the role of public and private teaching hospitals: 1988-1991.HealthDennis P. Andrulis, Kevin B. Weiss, Carla M. McGregor, Kelly Lang Ramirez, Caren A. Ginsberg, Yoku Shaw-Taylor
Validity of the Karnofsky Performance Status in an HIV-infected sample.HealthDeborah P. Lubeck, Michael W. O'Dell, Peter O'Driscoll, Suzie Matsuno
Viral load in peripheral blood mononuclear cells as surrogate for clinical progression.(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthRonald B. Moss, Dennis J. Carlo, Francoise Ferre, Anne Daigle, Steven P. Richieri, Fred Jensen
Viral phenotype and geneotype as markers in clinical trials.(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthDavid A. Katzenstein
Viral resistance and the selection of antiretroviral combinations.(Combination Antiretroviral Therapy for HIV Infection: Proceedings of an International Symposium held in Berlin, Germany, March 25-26, 1995)HealthBrendan A. Larder
Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection.HealthMichael P. Busch, Homayoon Farzadegan, George M. Shaw, Stephen J. Clark, Denis R. Henrard, Eric Daar, Jack Phillips
Virologic parameters as surrogate markets for clinical outcome in HIV-1 disease: verification, variation and validation.(Surrogate Markers of HIV: Strategies and Issues for Selection and Use)HealthRobert W. Coombs, Patricia S. Reicherdorfer
Vitamin A deficiency in non-vitamin-supplemented patients with AIDS: a cross-sectional study.HealthAndrew J. Karter, Dennis L. Karter, Robert Yarrish, Claire Patterson, Philip H. Kass, Jill Nord, Jay Ward Kislak
Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.HealthJames O. Kahn, Lee Ratner, Susan E. Krown, John M. Bennett, Josephine Paredes, William P. Tong, Michael L. Feldstein, Silan Lin, Craig E. Metroka
Weight loss prior to clinical AIDS as a predictor of survival.HealthLawrence Kingsley, Neil M.H. Graham, Alfred J. Saah, John P. Palenicek, Y. David He, Donald A. Hoover, John S. Oishi
Welcoming presentation to the Henry J. Kaiser Family Foundation Forum on AIDS and Managed Care.HealthDavid M. Lawrence
Working toward a common currency: is standardization of cost-effectiveness analysis possible?(Supplement 4: Cost-Effectiveness and AIDS: Science and Marketing?)HealthBryan R. Luce
Zidovudine for the prevention of vertical HIV transmission: a decision analytic approach.HealthSten H. Vermund, Robert L. Goldenberg, John (British judge) Owen, Dwight J. Rouse
Zygomycosis (mucormycosis) and HIV infection: report of three cases and review.HealthFrederick L. Altice, Hetty A. Waskin, Stephanie E. Nagy-Agren, Peiguo Chu, G.J. Walker Smith
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.